Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 117498
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.117498
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.117498
Table 1 Baseline patient characteristics, mean ± SD/n (%)
| Characteristics | Recurrence group (n = 18) | Non-recurrence group (n = 56) | χ²/t/Z value | P value |
| Sex | ||||
| Men | 14 (77.8) | 41 (73.2) | 0.006 | 0.940 |
| Women | 4 (22.2) | 15 (26.8) | ||
| Age (years) | 70.61 ± 10.87 | 68.82 ± 11.32 | 0.589 | 0.558 |
| Tumor differentiation | ||||
| Poorly differentiated | 14 (77.8) | 33 (58.9) | 2.419 | 0.298 |
| Moderately differentiated | 3 (16.7) | 13 (23.2) | ||
| Well-differentiated | 1 (5.6) | 10 (17.9) | ||
| TNM stage | ||||
| Stage II | 6 (33.3) | 32 (57.1) | 3.091 | 0.079 |
| Stage III | 12 (66.7) | 24 (42.9) | ||
| Lymph node metastasis | ||||
| Present | 4 (33.3) | 20 (42.9) | 1.132 | 0.287 |
| Absent | 14 (66.7) | 36 (57.1) |
- Citation: Qi Y, Wu CX. Association of carcinoembryonic antigen/carbohydrate antigen 19-9 with gastric cancer recurrence and chemotherapy toxicities. World J Gastrointest Oncol 2026; 18(4): 117498
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/117498.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.117498